1: Safe administration and dosing of EGFR inhibitors in NSCLC - Practical guidance for oncology nurses
8 Jun 2026
1: Safe administration and dosing of EGFR inhibitors in NSCLC - Practical guidance for oncology nurses
2: Managing EGFR inhibitor side effects in NSCLC - Skin toxicity impact, adherence challenges, and nursing management
3: MDT collaboration in NSCLC - Aligning oncologists, nurses, and patients to enhance EGFR inhibitor treatment pathways and supportive care